Literature DB >> 3207552

Correction of systolic time intervals for heart rate: a comparison of individual with population derived regression equations.

S J Warrington1, K Weerasuriya, C D Burgess.   

Abstract

1. We have examined the problem of how systolic time intervals (STI) should be corrected for heart rate in clinical pharmacological studies. 2. 'Individual' linear regression equations describing the relationship between STI and heart rate were derived for each of 43 healthy young adults (30 men and 13 women) by measuring STI at different heart rates produced by incremental doses of intravenous atropine. 'Population' equations for each sex were obtained by taking the mean of the 'individual' regression coefficients. 3. In order to assess which method more effectively reduced variability of the STI, 'individual' regression coefficients were derived for eight men who had previously participated in a placebo-controlled study which had used STI to test the cardiovascular effects of calcium antagonists alone and in combination with propranolol. 4. Within-subject variability in rate-corrected STI was similar after application of 'individual' and 'population' regression equations. Between-subject variability tended to be less after the use of 'population' equations. 5. 'Population' regression equations were more effective than 'individual' regression equations in allowing detection of differences between treatments, as judged by F values from ANOVA. 6. In clinical pharmacological studies including measurements of STI in healthy young subjects, 'individual' regression equations appear to have no advantage over 'population' equations derived in a group of subjects of similar age and sex.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3207552      PMCID: PMC1386522          DOI: 10.1111/j.1365-2125.1988.tb03381.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  12 in total

1.  Influence of heart rate increase on uncorrected pre-ejection period/left ventricular ejection time (PEP/LVET) ratio in normal individuals.

Authors:  D V Cokkinos; E T Heimonas; J N Demopoulos; A Harralambakis; G Tsartsalis; C D Gardikas
Journal:  Br Heart J       Date:  1976-07

2.  Evaluation of some non-invasive indices of cardiovascular function [proceedings].

Authors:  C D Burgess; J Wadsworth; S J Warrington
Journal:  Br J Clin Pharmacol       Date:  1979-04       Impact factor: 4.335

3.  Rate corrected systolic time intervals and Valsalva manoeuvre.

Authors:  C Layton; H Di Nunzio; G Gent; P Freedman; A McDonald
Journal:  Br Heart J       Date:  1973-03

4.  Systolic time intervals in heart failure in man.

Authors:  A M Weissler; W S Harris; C D Schoenfeld
Journal:  Circulation       Date:  1968-02       Impact factor: 29.690

5.  Right and left ventricular systolic time intervals. Effects of heart rate, respiration and atrial pacing.

Authors:  R F Leighton; A M Weissler; P B Weinstein; C F Wooley
Journal:  Am J Cardiol       Date:  1971-01       Impact factor: 2.778

6.  Systolic time intervals--a new technique in clinical pharmacology.

Authors:  S Warrington
Journal:  Methods Find Exp Clin Pharmacol       Date:  1985-02

7.  The prediction of individual systolic time interval v heart rate regression equations.

Authors:  A W Kelman; D J Sumner; B Whiting
Journal:  Br J Clin Pharmacol       Date:  1981-07       Impact factor: 4.335

8.  Systolic time interval v heart rate regression equations using atropine: reproducibility studies.

Authors:  A W Kelman; D J Sumner; B Whiting
Journal:  Br J Clin Pharmacol       Date:  1981-07       Impact factor: 4.335

9.  A comparison of the hemodynamic effects of tachycardia produced by atrial pacing and atropine.

Authors:  B D Kosowsky; E Stein; S H Lau; J W Lister; J I Haft; A N Damato
Journal:  Am Heart J       Date:  1966-11       Impact factor: 4.749

10.  Noninvasive assessment of the cardiovascular effects of prostacyclin (PGI2) in man.

Authors:  S J Warrington; P R Smith; J O'Grady
Journal:  Eur J Cardiol       Date:  1980
View more
  7 in total

1.  Investigation of possible pharmacokinetic and pharmacodynamic interactions between epanolol and digoxin.

Authors:  R A Lefebvre; M G Bogaert; D Duprez
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Evaluation of cardiac beta 1-adrenergic sensitivity with dobutamine in healthy volunteers.

Authors:  F Pousset; S Chalon; P Thomaré; B Diquet; P Lechat
Journal:  Br J Clin Pharmacol       Date:  1995-06       Impact factor: 4.335

3.  Left ventricular ejection time is an independent predictor of incident heart failure in a community-based cohort.

Authors:  Tor Biering-Sørensen; Gabriela Querejeta Roca; Sheila M Hegde; Amil M Shah; Brian Claggett; Thomas H Mosley; Kenneth R Butler; Scott D Solomon
Journal:  Eur J Heart Fail       Date:  2017-09-04       Impact factor: 15.534

4.  Ketotifen and cardiovascular effects of xamoterol following single and chronic dosing in healthy volunteers.

Authors:  R F Schäfers; I Karl; K Mennicke; A E Daul; T Philipp; O E Brodde
Journal:  Br J Clin Pharmacol       Date:  1999-01       Impact factor: 4.335

5.  The extrapulmonary effects of inhaled hexoprenaline and salbutamol in healthy individuals.

Authors:  P Bremner; C Burgess; G Purdie; R Beasley; J Crane
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

6.  Cardiovascular effects of fenoterol under conditions of hypoxaemia.

Authors:  P Bremner; C D Burgess; J Crane; D McHaffie; D Galletly; N Pearce; K Woodman; R Beasley
Journal:  Thorax       Date:  1992-10       Impact factor: 9.139

7.  Cardiovascular effects of eating, atenolol and their interaction: beta1-adrenergic modulation does not play a predominant role in the genesis of postprandial effects.

Authors:  C De Mey; D Enterling; I Meineke
Journal:  Br J Clin Pharmacol       Date:  1993-11       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.